Alpha 2.0
Login Register
» Authors » Kenneth M Lynn

Kenneth M Lynn

Explore the profile of Kenneth M Lynn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 179
Followers 0
Related Specialties
Infectious Diseases
Pharmacology
Top 10 Co-Authors
Luis J Montaner
Karam Mounzer
Pablo Tebas
Livio Azzoni
Bonnie J Howell
Emmanouil Papasavvas
Lynda Dee
Daria J Hazuda
Karine Dube
Sukyung Kim
Published In
J Infect Dis
HIV Res Clin Pract
J Pers Med
AIDS
Clin Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions
Dube K, Agarwal H, Carter W, Dee L, Taylor J, Roebuck C, et al.
HIV Res Clin Pract . 2022 Aug; 23(1):76-90. PMID: 35968737
: HIV cure-directed clinical trials using analytical treatment interruptions (ATIs) require participants to adhere to frequent monitoring visits for viral load tests. Novel viral load monitoring strategies are needed to...
2.
"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States
Dube K, Kanazawa J, Roebuck C, Johnson S, Carter W, Dee L, et al.
HIV Res Clin Pract . 2022 Mar; 23(1):120-135. PMID: 35348047
Background: People with HIV (PWH) and community members have advocated for the development of a home-based viral load test device that could make analytical treatment interruptions (ATIs) less burdensome. Objective:...
3.
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States
Dube K, Eskaf S, Hastie E, Agarwal H, Henley L, Roebuck C, et al.
J Pers Med . 2022 Feb; 12(2). PMID: 35207719
Frequent viral load testing is necessary during analytical treatment interruptions (ATIs) in HIV cure-directed clinical trials, though such may be burdensome and inconvenient to trial participants. We implemented a national,...
4.
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy
Papasavvas E, Azzoni L, Ross B, Fair M, Yuan Z, Gyampoh K, et al.
Clin Infect Dis . 2021 Feb; 72(3):495-498. PMID: 33527127
Accurate characterization of the human immunodeficiency virus (HIV) reservoir is imperative to develop an effective cure. HIV was measured in antiretroviral therapy-suppressed individuals using the intact proviral DNA assay (IPDA),...
5.
Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals
Giron L, Azzoni L, Yin X, Lynn K, Ross B, Fair M, et al.
AIDS . 2020 Jul; 34(10):1461-1466. PMID: 32675559
Objective: Glycosylation plays a critical role in mediating several antibody (mainly immunoglobulin G; IgG) immunological functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), and anti-inflammatory activities. We investigated whether IgG glycosylation and...
6.
Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen
Azzoni L, Foulkes A, Papasavvas E, Mexas A, Lynn K, Mounzer K, et al.
J Infect Dis . 2013 Apr; 208(2):363. PMID: 23570845
No abstract available.
7.
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration
Azzoni L, Foulkes A, Papasavvas E, Mexas A, Lynn K, Mounzer K, et al.
J Infect Dis . 2012 Oct; 207(2):213-22. PMID: 23105144
Background: Antiretroviral therapy (ART)-mediated immune reconstitution fails to restore the capacity of the immune system to spontaneously control human immunodeficiency virus (HIV) replication. Methods: A total of 23 HIV type...